
<html>
        <meta charset="UTF-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        <link rel="icon" type="image/x-icon" href="../images/favicon.ico">
        <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.1.1/css/all.min.css">
        <title id="title">News'n'Clues - HEALTH Article Summaries - 2025-09-11</title>
        <script src="https://cdn.tailwindcss.com"></script>
        <style>
            .menu { color: #444444; }
            .copyright { margin: 0 auto; }
            p { font-family: serif; }
            body {  background-color: #2c2c2c; font-family: Arial, sans-serif; font-size: 20px; color: #f4f4f4;  }
            a { text-decoration: none; color: #f4f4f4; }
            .section { margin-bottom: 20px; }
            .heading {
                font-size: 2rem;
                font-weight: bold;
                background: linear-gradient(90deg, #fc4535, #1a6198);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                text-shadow: 1px 1px 2px rgba(0, 0, 0, 0.2);
                line-height: 1.3; /* Prevents letters from being cut off */
                padding-bottom: 5px; /* Ensures space below the text */
                margin: 30px;
            }
            .hidden {
                display: none;
            }            
            
        </style>
    </head>
    <body>
        <div id="banner" class="w-full">
            <img src="../images/banner.jpg" alt="News Banner">
        </div>

        <div id="title" class="w-full flex items-center" style="background-color: #fc4535;">
          <a href="../index.html"><img src="../images/logo.jpg" alt="News Logo" class="h-auto"></a>
          <div class="flex-grow text-center">
              <div id="title_heading" class="text-4xl font-bold mb-4" style="color:#1a6198;">Article Summaries</div>
          </div>
        </div>
        <div id='category_heading' class="section text-center heading">
            HEALTH
        </div>
        <div id="articles">
            
                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.news-medical.net/news/20250911/Study-examines-how-symptoms-of-adolescent-ADHD-and-ODD-are-related-to-adult-income.aspx'>Study examines how symptoms of adolescent ADHD and ODD are related to adult income</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.news-medical.net', 'title': 'News-Medical'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 13:55:00
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>Researchers at the University of Oulu's Research Unit of Clinical Medicine and Oulu Business School have examined how symptoms of adolescent ADHD (attention-deficit/hyperactivity disorder) and oppositional defiant disorder (ODD) are related to adult income. Instead, the impact is seen indirectly, through education and other psychiatric disorders. The effect was strongest among individuals with symptoms of both ADHD and ODD: their incomes were on average 25 per cent lower through the pathway of education and 18 per cent lower through other psychiatric disorders. In addition, national registers were used to obtain information on education, annual income, psychiatric disorders and background factors. ODD is a common comorbid disorder of ADHD, occurring in about 30 per cent of those diagnosed with ADHD. The large-scale data also made it possible to examine the independent effects of ODD symptoms – an area where research has previously been scarce and partly contradictory. According to Sampo Seppä, the lead author of the study, the results are encouraging: “Symptoms of adolescent ADHD and ODD were not in themselves associated with lower income levels in adulthood,” Seppä explains. However, his earlier research has shown that ADHD and ODD symptoms impair school performance during adolescence, lower educational attainment in adulthood, and increase the risk of unemployment and sickness absence. These new findings add to our understanding of why young people with ADHD tend to fare worse in working life on average. “I hope this research will help to increase appreciation of investments in education and mental health services, so that the consequences of neurodevelopmental disorders can be reduced at the population level,” Seppä concludes. Indirect associations between adolescent ADHD and/or oppositional defiant disorder symptoms and adult incomes: the mediating roles of education and co-occurring psychiatric disorders. Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion. In this interview, Jonathan Ferguson discusses how knowledge of an emerging public health concern identified at Pittcon 2024 has evolved a year on. Explore how the Bruker Vutara VXL advances single-molecule imaging across DNA, RNA, and proteins News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. A few things you need to know before we start. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information.</p>
                <br/>
                

                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.medscape.com/viewarticle/dupilumab-shows-sustained-benefits-chronic-rhinosinusitis-2025a1000o3r'>Dupilumab Shows Sustained Benefits in Chronic Rhinosinusitis With Nasal Polyps</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.medscape.com', 'title': 'Medscape'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 13:11:09
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>

Edited by Mandeep Singh Rawat

 September 11, 2025  

In an Italian study involving more than 900 patients with chronic rhinosinusitis with nasal polyps (CRSwNP), dupilumab reduced NP scores and alleviated nasal obstruction at 2 years. Over 91% of patients had a good-to-excellent response, with approximately 19% successfully extending treatment intervals to every 4 weeks.

“[The study] results contribute to the growing evidence supporting dupilumab's role as a cornerstone therapy for severe CRSwNP,” the authors wrote. 

Eugenio De Corso, MD, PhD, with A. Gemelli University Hospital Foundation IRCCS, Rome, Italy, was the corresponding author of the study, which was published online on August 30, 2025 in Allergy.

The absence of a control group, retrospective data collection, and inclusion of only Italian participants may have limited generalizability. The proposed criteria for disease control and remission were not validated or standardized through consensus-based guidelines.

Several authors reported receiving lecture fees from and participating in expert board meetings for various pharmaceutical companies. 

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Send comments and news tips to news@medscape.net.</p>
                <br/>
                

                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.news-medical.net/news/20250911/Antibody-cocktail-could-change-the-way-the-world-fights-influenza.aspx'>Antibody cocktail could change the way the world fights influenza</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.news-medical.net', 'title': 'News-Medical'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 05:08:00
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>In a new study in Science Advances, researchers report that a cocktail of antibodies protected mice-including those with weakened immune systems-from nearly every strain of influenza tested, including avian and swine variants that pose pandemic threats. Unlike current FDA-approved flu treatments, which target viral enzymes and can quickly become useless as the virus mutates, this therapy did not allow viral escape, even after a month of repeated exposure in animals. That difference could prove crucial in future outbreaks, when survival often depends on how quickly and effectively doctors can deploy treatments and vaccine development will take about six months. This is the first time we've seen such broad and lasting protection against flu in a living system. Silke Paust, immunologist at JAX and senior author of the study The insights challenge a long-held belief that for antibodies to be useful as a therapy against viruses they must be "neutralizing" antibodies that bind directly to viruses and block them from infecting cells. This new approach could reshape how scientists design treatments for other viruses. "The majority of antibodies our bodies make are non-neutralizing, but medicine has largely ignored them," Paust explained. Even with lethal strains like H5 and H7 avian flu, this therapy saved lives long after infection had taken hold." This part of the virus is essential for its life cycle and remains nearly unchanged across infected cells in all flu strains, including human, avian, and swine variants. The therapy did not lead to viral resistance even after repeated exposure, and sequencing confirmed no mutations in the virus's M2 region after 24 days of treatment. "The virus didn't mutate away even when using individual antibodies," Paust said. "But in a flu season with millions of people taking this therapy, I would be much more confident that we can prevent escape from the therapy if we use the cocktail." When testing H7N9, a type of bird flu that can be deadly to both animals and people, the team found that just one dose of the treatment reduced the amount of virus in the lungs, even when it was given four days after infection. The reduced viral loads correlated with better survival rates. All mice survived when treated with the antibody cocktail on the first three days after infection, while 70% and 60% survived on days four and five, respectively. "We can use very low doses, which is also promising because potential therapies could be cheaper and less likely to produce adverse side effects in people," Paust said. Currently, flu vaccines are updated seasonally because the virus continuously mutates, making immunity to prior strains irrelevant. "We need something that is off the shelf when we don't necessarily have the time to make a new vaccine if we do have an outbreak or pandemic where lethality is high, so this type of therapy could be readily available for anyone in any situation," Paust said. The team is working on designing antibodies for clinical trials. The team envisions a future where the cocktail could work as a standalone prophylactic for elderly, immunocompromised, and other high-risk groups, in addition to serving as a therapy for those severely ill with flu. Other authors are Teha Kim of The Jackson Laboratory; Lynn Bimler and Amber Y. Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion. In this interview, Jonathan Ferguson discusses how knowledge of an emerging public health concern identified at Pittcon 2024 has evolved a year on. Explore how the Bruker Vutara VXL advances single-molecule imaging across DNA, RNA, and proteins News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. A few things you need to know before we start. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information.</p>
                <br/>
                

                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.news-medical.net/news/20250911/Treating-opioid-use-disorder-during-incarceration-improves-post-release-outcomes.aspx'>Treating opioid use disorder during incarceration improves post-release outcomes</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.news-medical.net', 'title': 'News-Medical'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 04:52:00
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>A study supported by the National Institutes of Health (NIH) finds that individuals who received medication for opioid use disorder (MOUD) while incarcerated were significantly more likely to continue treatment six months after release than those who did not receive MOUD. These outcomes underscore the importance of providing MOUD treatment during incarceration. Published in The New England Journal of Medicine, the study analyzed data from 6,400 people with probable opioid use disorder who were incarcerated in seven Massachusetts county jails between September 2019 and December 2020. "These findings demonstrate the importance of providing medications to treat opioid use disorder in correctional settings," said Nora D. Volkow, M.D., Director of NIDA. "Offering effective opioid treatment to people in jail is a critical step toward addressing the opioid crisis, promoting recovery, saving lives and reducing reincarceration. People with opioid use disorder are overrepresented in jails compared to the general population. Despite their effectiveness, MOUD is available in only about 13% of U.S. jails and is often restricted to specific groups, such as pregnant women. This limited access contributes to forced withdrawal, increasing the risk of relapse and overdose post-release. In response, a 2018 state law mandated a four-year pilot program to provide all U.S. Food and Drug Administration-approved MOUD-buprenorphine, methadone, and naltrexone-in five county jails, with two additional jails voluntarily joining the program. The law requires that individuals already receiving treatment for opioid use disorder continue it during detention, begin treatment before release when appropriate, and be connected to community care after release. These data were integrated with the Massachusetts Public Health Data Warehouse, which links over 35 state databases to track treatment for substance use disorders, incarceration, mortality, and other public health indicators. This linkage enabled a robust analysis of the program's impact on key post-release outcomes. Treatment in jail was strongly associated with better outcomes after release. Within the first 30 days, 60.2% of those who received MOUD in jail, initiated treatment in the community, compared to only 17.6% of individuals who weren't treated. Six months after release, 57.5% of those who received treatment in jail continued receiving MOUD, compared to just 22.8% of those who did not. Most people treated in jail received buprenorphine (67.9%) followed by methadone (25.7%) and naltrexone (6.5%). Peter D. Friedmann, M.D., M.P.H., lead author and addiction medicine physician, University of Massachusetts Chan Medical School Senior author Elizabeth A. Evans, PhD, a public health professor from University of Massachusetts-Amherst added, "Establishing these types of programs in local jails is a powerful and effective strategy for engaging and retaining people in treatment and reducing overdose deaths after release." Future research should explore the generalizability of these findings to other correctional systems, as well as how outcomes differ across population subgroups and by the type of medication received. This research was supported by the Justice Community Opioid Innovation Network (JCOIN), a nationwide research program that tests strategies to expand effective treatment, recovery, and related services for individuals with opioid use disorder involved in the criminal justice system. Friedmann, P. D., et al. (2025) Medications for Opioid Use Disorder in County Jails: Outcomes After Release . Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion. In this interview, Jonathan Ferguson discusses how knowledge of an emerging public health concern identified at Pittcon 2024 has evolved a year on. Explore how the Bruker Vutara VXL advances single-molecule imaging across DNA, RNA, and proteins News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. A few things you need to know before we start. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information.</p>
                <br/>
                

                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.news-medical.net/news/20250911/Infection-or-stressful-events-during-pregnancy-may-increase-anxiety-risk-in-offspring.aspx'>Infection or stressful events during pregnancy may increase anxiety risk in offspring</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.news-medical.net', 'title': 'News-Medical'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 04:40:00
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>Increased risk for anxiety may begin before birth, shaped by infection or stressful events during pregnancy, according to a new preclinical study from researchers at Weill Cornell Medicine. While scientists have long known that maternal difficulty during pregnancy may raise a child's risk for psychiatric illness, the biological pathways between these prenatal experiences and later mental health have been unclear. The researchers discovered that adversity in the womb configured a small percentage of these brain cells to be overly active when faced with a threatening situation, creating a vulnerability to anxiety. "This mechanism may help explain the persistent stress sensitivity and avoidance seen in some individuals with innate anxiety." To mimic adverse conditions in the womb, the researchers used a mouse model that develops abnormal immune activity during pregnancy. When tested, their genetically normal offspring grew up to show classic signs of anxiety, such as avoiding open spaces and over-responding to stress. But how does an inflammatory environment in the womb cause lasting changes in the brain that may lead to anxiety? These chemical tags help control which genes are turned on and off. They also used single-cell RNA sequencing to map the genes that were activated abnormally. These changes are called "epigenetic" because they don't alter the actual genetic code but affect how cells read and use that code. Surprisingly, the researchers uncovered thousands of sites where DNA methylation was altered, especially in regions that act as "on-off switches" for genes controlling synapses—the connections that allow neurons to communicate. They observed that some neurons were more affected than others. These neurons exhibited both altered DNA methylation and abnormal expression of genes related to synaptic function. "Overall, these epigenetic changes are instructing certain neurons in the vDG to respond differently in adulthood when faced with unsafe environments," explained Dr. Kristen Pleil, associate professor of pharmacology at Weill Cornell Medicine, who co-led this research. The researchers then monitored these neurons in real time. But in mice exposed to prenatal adversity, activity surged as soon as they started thinking about transitioning from safety into a threatening space. This study provides one of the clearest mechanistic links yet between prenatal environment, epigenetic change and psychiatric risk, but is only a starting point. The researchers plan to tease out more mechanistic details. Next, we really want to understand why these certain cells are epigenetically programmed." A better understanding of this mechanism may help guide the search for similar epigenetic signatures in people, which could serve as early biomarkers of risk. The specific synapse-related genes that are abnormally programmed in these "primed" neurons may also potentially lead to therapeutic targets. The findings underscore the importance of maternal health during pregnancy—not just for physical outcomes like birth weight, but also for shaping long-term brain function. Adverse gestational environment configures a subpopulation of ventral dentate granule cells for recruitment to drive innate anxiety. Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion. In this interview, Jonathan Ferguson discusses how knowledge of an emerging public health concern identified at Pittcon 2024 has evolved a year on. Explore how the Bruker Vutara VXL advances single-molecule imaging across DNA, RNA, and proteins News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. A few things you need to know before we start. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information.</p>
                <br/>
                

                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.news-medical.net/news/20250911/Harnessing-the-power-of-AI-to-boost-HPV-vaccine-uptake-among-teens.aspx'>Harnessing the power of AI to boost HPV vaccine uptake among teens</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.news-medical.net', 'title': 'News-Medical'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 04:35:00
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>A new project led by University of Maryland communication Professor Xiaoli Nan aims to change those discouraging statistics by harnessing the power of artificial intelligence to help parents make informed choices. Backed by a $2.8 million grant from the National Institutes of Health's National Cancer Institute, Nan and an interdisciplinary team of researchers are developing a personalized, AI-driven chatbot that tailors health information to parents' specific concerns and communication styles. This vaccine is safe, effective and prevents several types of cancer, but many parents still hesitate. But misinformation, stigma and distrust have slowed its widespread adoption, said Knott, who is also associate director of community outreach and engagement at the University of Maryland Marlene and Stuart Greenebaum Comprehensive Cancer Center in Baltimore. Some parents hear that and wonder if it's too soon, choosing to delay or avoid vaccination altogether. "The literature shows that this vaccine is underutilized especially in certain groups, for example men, those with less education, and those with less access to health care," Knott said. While traditional communication tools-like brochures and websites-often fail to address concerns at an individual level, the research team's AI-powered chatbot will use natural language processing to simulate human conversation. But it goes further, tailoring messages to a user's specific beliefs, concerns and communication preferences. Unlike scripted chatbots that only deliver canned replies-or generative AI models like ChatGPT, which can produce unreliable text-the team's system draws on large language models in a more controlled way. Resnik describes this as a "middle ground" approach: not limited to rigid, prewritten scripts, but also not the "wild west" of open-ended text where "guardrails" have often proven ineffective. Once refined, the chatbot will be tested in two randomized controlled trials. The first will be conducted online with a national sample of U.S. parents, comparing the chatbot's impact to a standard CDC pamphlet. Qi Wang said the "tailored, timely and actionable communication" enabled by AI "represents a paradigm shift in public health communication, moving beyond traditional methods to address the specific needs and concerns of parents who have adolescent children." Beyond its potential to drive vaccine uptake, the researchers hope to demonstrate how AI can help public health systems respond more quickly, thoughtfully and inclusively-especially in times of crisis. In future pandemics or other fast-moving public health challenges, tools like the chatbot could offer a scalable, adaptable solution for reaching people with timely, personalized guidance, Nan said. The project "really makes people think about what's possible," she said. "Can we do a better job with public health communication-with speed, scale and empathy? Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion. In this interview, Jonathan Ferguson discusses how knowledge of an emerging public health concern identified at Pittcon 2024 has evolved a year on. Explore how the Bruker Vutara VXL advances single-molecule imaging across DNA, RNA, and proteins News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. A few things you need to know before we start. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information.</p>
                <br/>
                

                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.news-medical.net/news/20250911/Study-quantifies-the-prevalence-of-suicidal-thoughts-among-university-students.aspx'>Study quantifies the prevalence of suicidal thoughts among university students</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.news-medical.net', 'title': 'News-Medical'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 04:32:00
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>This is a group in which suicidal ideation has increased significantly in recent years, surpassing the general population. The study included nearly 73,000 university students, most of them in their first year, from 71 universities across 18 countries between 2017 and 2023. Participating countries included Germany, Saudi Arabia, Australia, Belgium, Canada, Spain, France, Kenya, Ireland, Northern Ireland, Mexico, New Zealand, the Netherlands, Romania, South Africa, Sweden, Chile, and China. Students were invited via email to complete a survey designed to assess whether they had ever experienced suicidal thoughts or attempts, as well as whether they had faced adverse life events or had mental health disorders. Responses from participants who completed the survey revealed that nearly half (47%) had experienced suicidal thoughts at some point in their lives, 26% had made a suicide plan, and 10% had attempted suicide. In the year prior to completing the survey, 30% reported having suicidal thoughts, 14% had made a plan, and 2.3% had attempted suicide. These rates are significantly higher than those of the general population. However, researchers caution that although these results are consistent with other studies, they may be slightly overestimated due to the self-selection of students with suicidal ideation into the survey. "All these factors carry risk-every traumatic event, every mental disorder, without exception, increases the risk of suicidal thoughts and suicide attempts," he adds. Another factor increasing the risk of suicidal thoughts is gender identity. Among transgender students, the risk is significantly higher-they are 2.4 times more likely to experience suicidal ideation and 3.6 times more likely to attempt suicide than other students. Researchers point out that this group is more likely to be exposed to multiple risk factors, including social ones. These conclusions can be extended to the broader LGBTQ+ population. In this regard, Dr. Jordi Alonso, coordinator of the Health Services Research Group at the Hospital del Mar Research Institute, Spanish coordinator of the WMH-ICS initiative, and principal investigator at CIBERESP, adds that "effective prevention must take into account the combination of risk factors-such as sex, gender identity, sexual orientation, and the accumulation of childhood disorders-which can create a biosocial feedback loop that increases suicide risk." Cal tenir en compte que l'adolescència és un període d'alt risc per a l'aparició de pensaments i conductes suïcides, que es poden mantenir fins a l'edat adulta. De fet, un terç dels joves experimenten ideació suïcida abans d'entrar a la universitat i molts casos persisteixen durant aquest període de la seva vida. "Identificar els factors de risc durant aquesta transició crítica és essencial per als esforços de prevenció", coincideixen Mortier i Alonso. It is important to note that adolescence is a high-risk period for the onset of suicidal thoughts and behaviors, which can persist into adulthood. In fact, one-third of young people experience suicidal ideation before entering university, and many cases continue during this period. This can result in poorer academic performance, dropout, long-term physical and mental health problems, and reduced quality of life. "Identifying risk factors during this critical transition is essential for prevention efforts," conclude Mortier and Alonso. The associations of childhood adversities and mental disorders with suicidal thoughts and behaviors - Results from the World Mental Health International College Student Initiative. Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion. In this interview, Jonathan Ferguson discusses how knowledge of an emerging public health concern identified at Pittcon 2024 has evolved a year on. Explore how the Bruker Vutara VXL advances single-molecule imaging across DNA, RNA, and proteins News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. A few things you need to know before we start. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information.</p>
                <br/>
                

                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.news-medical.net/news/20250911/New-funding-opportunities-aim-to-advance-bipolar-disorder-research.aspx'>New funding opportunities aim to advance bipolar disorder research</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.news-medical.net', 'title': 'News-Medical'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 04:27:00
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>Today, Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) announced the opening of a fourth round of funding opportunities for the Discovery Research program. Successful teams will undertake groundbreaking research into the genetic, molecular, cellular, circuit, and behavioral mechanisms of bipolar disorder, especially applications that address the following: By prioritizing hypothesis-driven, collaboration-forward science, this program is expanding the idea space for new treatments, diagnostic tools, and a deeper foundational understanding of bipolar disorder. Scaled science of this kind is redefining what's possible in the field." "The fourth round of funding for the Discovery Research program is a significant milestone toward continuing to make real and impactful discoveries that can drive new therapies and interventions in bipolar disorder." said Eric J. Nestler, MD, PhD, Icahn School of Medicine at Mount Sinai, and Chair, BD² Research Programs. "This program continues to connect researchers, drive innovative thinking, and champion real-time data sharing and open access practices that can close fundamental gaps in our understanding of bipolar disorder." Through its emphasis on collaboration, data sharing, and interdisciplinary approaches, BD2 is reshaping the landscape of bipolar disorder research. Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion. In this interview, Jonathan Ferguson discusses how knowledge of an emerging public health concern identified at Pittcon 2024 has evolved a year on. Explore how the Bruker Vutara VXL advances single-molecule imaging across DNA, RNA, and proteins News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. A few things you need to know before we start. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. Please do not ask questions that use sensitive or confidential information.</p>
                <br/>
                

                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.news-medical.net/news/20250910/Genes-play-an-active-role-in-shaping-the-gut-bacteria-study-finds.aspx'>Genes play an active role in shaping the gut bacteria, study finds</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.news-medical.net', 'title': 'News-Medical'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 03:04:00
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>New research from the University of Sydney's Charles Perkins Centre has found that genes play an active role in shaping the bacteria found in our gut, questioning the idea that gut health is influenced only by diet. The gut microbiome is increasingly seen as vital to overall health, with Australia's gut health supplement industry valued at over $400 million in 2024. After decades of research linking the gut microbiome to almost every chronic disease, it may seem like we're all being held hostage by the bugs that live inside us. While gut microbes certainly influence everything from diabetes to depression, this study has revealed that our bodies aren't just passive hosts." The researchers found that mice with certain genes produced natural peptides – or small proteins – called alpha-defensins, which act as gardeners of the microbiome, shaping which gut bugs thrive and weeding out undesirable bacteria. The mice with alpha-defensins had healthier microbiomes and were much less likely to develop insulin resistance, a key cause of type 2 diabetes and heart disease. Importantly, alpha-defensin peptides are also found in people, which the researchers believe is highly relevant to human health. Professor David James, joint Interim Academic Director of the Charles Perkins Centre, said: "Our work suggests that our DNA actively works to shape a healthy gut microbiome, and these microbial-shaping peptides could one day, if harnessed, become a new weapon against obesity and diabetes." "Mice and humans seem to have evolved many defensin genes, each making a different peptide. It is thought that this diversity allows our immune system to fend off a wide range of attackers". Critically, while certain genetic strains of mice gained benefit from the defensin peptides, others did not and were, in fact, worse off. "This shows the importance of 'personalised medicine', or tailoring treatments to complement the genes of individuals rather than taking a one-size-fits-all approach to medications," Dr Masson said. "We need to establish how different individuals and microbiomes react to the same treatments, whether they be defensin peptides or common medications already in use." Dr Masson said the team is now looking to expand on the research and explore how it applies to human health. We know the microbiome is involved in many chronic diseases like cancer; I suspect defensins could play a role in this field." Professor James said that this illustrates the potential power of precision medicine. "Our work clearly shows how manipulating the gut microbiome with these peptides benefits some but not others," he said. "This highlights both the potential of precision medicine and the potential dangers of trying to alter our gut microbiome, such as with supplements or even fad diets, before we know more about how our bodies maintain healthy microbiomes unique to each of us. "We are at the foothills of precision medicine, and the picture looks promising, but we have a long way to go." Masson, S. W. C., et al. (2025) Genetic variance in the murine defensin locus modulates glucose homeostasis. Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion. In this interview, Jonathan Ferguson discusses how knowledge of an emerging public health concern identified at Pittcon 2024 has evolved a year on. Explore how the Bruker Vutara VXL advances single-molecule imaging across DNA, RNA, and proteins News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. A few things you need to know before we start. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information.</p>
                <br/>
                

                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.news-medical.net/news/20250910/Can-cannabis-use-disrupt-womene28099s-fertility-New-study-finds-strong-evidence.aspx'>Can cannabis use disrupt women's fertility? New study finds strong evidence</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.news-medical.net', 'title': 'News-Medical'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 01:28:00
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>New evidence shows that THC in cannabis can accelerate egg maturation but increase chromosomal errors, reducing healthy embryo development and raising concerns for women undergoing IVF. Their findings showed links between THC exposure and outcomes relevant to reproductive health, including a positive association with oocyte nuclear maturation alongside lower embryo euploid rates, chromosome segregation errors, and atypical spindle morphology. Cannabis use has been rising worldwide, both for medical and recreational purposes, with THC levels in products increasing from about 3% in the 1980s to as high as 30% today. While numerous studies have shown that THC negatively impacts male fertility, affecting the methylation, concentration, morphology, and motility of sperm deoxyribonucleic acid (DNA), its influence on female reproductive cells remains poorly understood. In vitro fertilization (IVF) offers a unique opportunity to study this process, as oocytes are retrieved along with the follicular fluid and surrounding supporting cells. Researchers investigated the impact of THC on oocyte health, gene expression, and chromosome segregation, combining laboratory experiments with clinical data. They used donated biological materials, including follicular fluid (FF) and immature oocytes, from IVF patients who had provided informed consent. Patients with poor fertility outcomes, advanced age, or THC exposure were excluded to ensure sample quality. For laboratory experiments, immature oocytes were divided into three groups: control, low-dose THC (reflecting physiological levels), and high-dose THC (based on animal studies). Oocytes were cultured for 24 hours, with maturation and key cellular events monitored using time-lapse imaging. Polar body biopsies were also performed for chromosome analysis using whole-genome sequencing. Data were analyzed with established bioinformatics pipelines and statistical tests, and clinical IVF outcomes were compared using a retrospective matched case-control design. Most contained the metabolite 11-COOH-THC, while Δ9-THC and 11-OH-THC were often detected together. Interestingly, 73% of THC-positive patients had not disclosed cannabis use. Concentrations of these metabolites were similar between FF and serum. In laboratory experiments, immature oocytes were cultured with physiologically relevant or higher concentrations of THC. While there was a non-significant trend toward higher maturation, THC exposure did not alter oocyte size, timing of key maturation events, or polar body extrusion. Low-dose THC exposure altered 316 genes (predominantly downregulated), while high-dose exposure affected 464 genes (predominantly upregulated), involving pathways related to inflammation, extracellular matrix remodeling, immune signaling, and chromosome segregation. Examples included downregulation of MMP9, a gene involved in extracellular matrix remodeling. This study shows that THC, the main psychoactive compound in cannabis, affects human oocytes by altering maturation, transcript profiles, chromosome segregation, and spindle organization. While THC appeared to accelerate oocyte maturation, it also disrupted critical molecular pathways, reduced embryo euploidy rates, and increased chromosomal errors, which may lower fertility outcomes. These findings align with some previous animal studies but provide direct evidence in human oocytes, highlighting potential risks for people undergoing IVF. A major strength of this research is its integrated approach, which combines retrospective clinical data with detailed in vitro experiments and measures THC metabolites directly, rather than relying on self-reports. However, limitations include the use of immature oocytes from stimulated cycles, a lack of power to examine effects by age, and missing data on cannabis consumption habits or co-exposures. Future studies should explore dose–response effects, mechanisms of THC action in oocytes, and long-term impacts on embryo development. Clinically, these findings emphasize the importance of counseling patients about potential fertility risks linked to cannabis use. Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion. In this interview, Jonathan Ferguson discusses how knowledge of an emerging public health concern identified at Pittcon 2024 has evolved a year on. Explore how the Bruker Vutara VXL advances single-molecule imaging across DNA, RNA, and proteins News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. A few things you need to know before we start. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information.</p>
                <br/>
                

                <div id='article_title' class='text-3xl text-gray-300 leading-tight'>
                    <a target='_blank' href='https://www.news-medical.net/health/Alzheimere28099s-Disease-and-Oral-Health.aspx'>How Oral Health Affects Alzheimer's: Inflammation, Pathogens, and Prevention</a>
                </div>
                <div id='article_attribution'  style='mb-1'>
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Source:</span> {'href': 'https://www.news-medical.net', 'title': 'News-Medical'}&nbsp;&nbsp;&nbsp;
                    <span class='text-1.5xl font-extrabold text-gray-500 leading-tight'>Published:</span> 2025-09-11 00:23:00
                    <i class="fas fa-chevron-down expand-icon text-gray-500" aria-hidden="true"></i>
                </div>
                <p class='hidden' class='text-gray-500'>This article explores how chronic periodontitis may contribute to Alzheimer's disease through systemic inflammation, oral pathogens, and neurodegenerative mechanisms. It highlights prevention, therapeutic strategies, and research directions linking oral health with brain aging. Periodontitis is often known as 'Gum Disease' and is a very common condition in which the gums and deeper periodontal structures become inflamed. Oral health is increasingly linked to systemic disease and brain aging. Alzheimer's disease (AD) is characterized by progressive cognitive decline with neuroinflammation, amyloid plaques, and neurofibrillary tangles. Converging clinical, epidemiological, and experimental work suggests that periodontal infections may amplify Alzheimer's risk through systemic cytokines, microglial activation, and the potential translocation of oral pathogens, such as Porphyromonas gingivalis, into the brain. Recent narrative and mechanistic reviews indicate that periodontitis is associated with a heightened risk of cognitive decline and dementia, with some reports approaching a ~2-fold elevation in AD risk.1,2,3,6 Representation of diverse systemic diseases and their relationship with periodontitis.2 Persistent plaque triggers chronic inflammation, deepening sulci into periodontal pockets that harbor anaerobes. Elevated systemic biomarkers such as alkaline phosphatase (ALP) have been reported to strengthen the association between severe periodontitis and lower cognitive performance.2,5 These inflammatory signals intersect AD biology: LPS and gingipains promote amyloid-beta (Aβ) accumulation, while outer membrane vesicles and gingipains enhance tau phosphorylation through glycogen synthase kinase-3 beta (GSK-3β). Large epidemiological cohorts report greater dementia and AD incidence in people with periodontitis, even after accounting for lifestyle factors. Experimental work demonstrates biological plausibility: oral infection with Porphyromonas gingivalis accelerates Aβ42 production, triggers neuroinflammation, and causes hippocampal neurotoxicity in animal models. Gingipain inhibitors directed at Kgp/Rgp have been shown preclinically to reduce brain bacterial load, inflammatory responses, and Aβ42 levels, with neuroprotective effects.3,4 Autopsy studies have detected microbial signatures in AD brains, including Porphyromonas gingivalis. Gingipains, cysteine proteases central to P. gingivalis pathogenicity, have been identified in AD brain tissue.3,4,6 Taken together, population-level associations, mechanistic animal studies, and clinical detection of periodontal pathogens in post-mortem AD tissue triangulate on a coherent model: chronic periodontal infection may contribute to AD pathogenesis. Prioritizing lifelong oral hygiene is a low-cost, high-yield strategy for brain health. Twice-daily brushing with fluoride, daily interdental cleaning, tobacco cessation, and biannual professional cleanings help limit periodontal inflammation throughout the lifespan. Adjunctive strategies under exploration include probiotics, oral microbiota replacement, and host-targeted anti-inflammatory approaches.7 In cohorts with severe periodontitis, attention to systemic inflammatory markers (e.g., ALP) may help identify individuals at higher risk.5 Preserving periodontal health is a practical and modifiable lever for dementia prevention. Despite growing signals linking periodontal disease and AD, key uncertainties remain. First, most evidence is observational, leaving the direction of effect unresolved: does chronic periodontal disease heighten neuroinflammation and accelerate Aβ pathology, or does prodromal AD impair self-care, worsening oral hygiene (reverse causation)? Definitions of periodontal disease, cognitive endpoints, sampling sites, and microbial assays differ. Many rely on small, clinic-based cohorts vulnerable to selection bias, short follow-up, and inadequate control of confounders such as age, diabetes, smoking, socioeconomic status, and medications. Field priorities include harmonized periodontal case definitions, adjudicated AD diagnoses supported by biomarkers, serial oral-microbiome and inflammatory profiling, and pragmatic trials testing periodontal therapy across the AD spectrum.1,3,6 Future work should prioritize precision antimicrobials that disrupt periodontal virulence without collapsing the commensal microbiota. Lead candidates include inhibitors of Porphyromonas gingivalis gingipains (lysine-specific Kgp and arginine-specific Rgp), as well as biofilm- or quorum-sensing blockers that reduce pathogenicity and antibiotic resistance.3,7 The parallel development of topical or locally delivered formulations could maximize pocket-level efficacy while minimizing systemic exposure. Together, these directions aim to restore oral ecological balance and reduce systemic sequelae. Oral health is a modifiable factor in AD risk. Chronic periodontitis sustains systemic inflammation and may permit periodontal pathogens, especially Porphyromonas gingivalis, Treponema denticola, and Fusobacterium nucleatum, to access the brain. These inflammatory and infectious routes make gum care a prevention target. Further research should clarify the causal mechanisms, validate biomarkers, and test targeted therapies (e.g., gingipain inhibitors, probiotics, anti-virulence strategies) in randomized controlled trials to determine the brain-health benefits.1,3,7 His academic journey has allowed him to delve deeper into understanding the intricate world of microorganisms. He has worked on diverse projects in microbiology, biopolymers, and drug delivery. His contributions to these areas have provided him with a comprehensive understanding of the subject matter and the ability to tackle complex research challenges. Please use one of the following formats to cite this article in your essay, paper or report: How Oral Health Affects Alzheimer's: Inflammation, Pathogens, and Prevention. "How Oral Health Affects Alzheimer's: Inflammation, Pathogens, and Prevention". "How Oral Health Affects Alzheimer's: Inflammation, Pathogens, and Prevention". How Oral Health Affects Alzheimer's: Inflammation, Pathogens, and Prevention. Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion. In this interview, Jonathan Ferguson discusses how knowledge of an emerging public health concern identified at Pittcon 2024 has evolved a year on. Explore how the Bruker Vutara VXL advances single-molecule imaging across DNA, RNA, and proteins News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. A few things you need to know before we start. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information.</p>
                <br/>
                

        </div>

        <script>
            // Get all article attribution elements
            const articleAttributions = document.querySelectorAll('#article_attribution');

            // Add an event listener to each attribution element
            articleAttributions.forEach(attribution => {
            attribution.addEventListener('click', () => {
                // Get the next paragraph element (the article text)
                const articleText = attribution.nextElementSibling;

                // Toggle the visibility of the article text
                articleText.classList.toggle('hidden');

                // Toggle the expand icon
                const expandIcon = attribution.querySelector('.expand-icon');
                expandIcon.classList.toggle('fa-chevron-down');
                expandIcon.classList.toggle('fa-chevron-up');
            });
            });    
        </script>

        <footer class="text-center text-sm text-gray-500 mt-12">
            <div class="inline-block align-middle">
                <a href="https://www.youtube.com/@news_n_clues" target="_blank" rel="noopener noreferrer"
                    class="flex items-center gap-2 text-red-600 hover:text-red-700 font-semibold transition duration-300 ease-in-out">
                    Watch Daily <span class="italic">News'n'Clues</span> Podcast on
                    <img src="../images/yt.png" width="16" height="16">
                </a>
            </div>
            <div>
                <a href="mailto:newsnclues@gmail.com?subject=News'n'Clues Aggregator Inquiry">SoftMillennium
                    <script>document.write(new Date().getFullYear());</script>
                </a>
                <!--
            <b>Copyright &copy; <script>document.write(new Date().getFullYear());</script> - <a href='mailto:newsnclues@gmail.com?subject=News Aggregator Inquiry'>News And Clues</a></b>
            -->
            </div>
        </footer>
    </body>
</html>
            